Loading...
MicroRNA-30c Reduces Hyperlipidemia and Atherosclerosis by Decreasing Lipid Synthesis and Lipoprotein Secretion.
Soh, James
Soh, James
Citations
Altmetric:
Journal Title
Keywords
Readers/Advisors
Hussain, M. Mahmood
Journal Title
Term and Year
Publication Date
2012-08-17
Type
Book Title
Publication Volume
Publication Issue
Publication Begin
Publication End
Number of pages
Files
Loading...
Doctoral Dissertation
Adobe PDF, 1.72 MB
Research Projects
Organizational Units
Journal Issue
Abstract
Excess lipids in plasma are a risk factor for cardiovascular and metabolic disorders. Our studies show that microRNA-30c (miR-30c) targets the 3 untranslated region (3 UTR) of MTP mRNA and induces degradation. This leads to reductions in the secretion of apolipoprotein B (apoB). In Western diet fed mice, miR-30c reduces hyperlipidemia and atherosclerosis by decreasing both the production of apoB-containing lipoproteins and lipid biosynthesis. The coordinate reductions are achieved without increasing hepatic lipids or increases in plasma transaminases. These studies suggest that miR-30c targets MTP, reduces apoB secretion, lowers plasma lipids, and prevents atherosclerosis. In addition, we hypothesized that miR-30c might target MTP mRNA more efficiently if the seed and supplementary sequences were studied further. Since miR-30c targets MTP mRNA by binding to 3 UTR via its seed and supplementary sequence, we designed various mutations in the miR-30c binding site of MTP.
The studies reveal the importance of the binding of the supplementary sequence in miR-30c with sequences in the 3 UTR of MTP. Furthermore, we also examined the role of miR-30c target genes involved in lipid synthesis. These studies have shed light on how miR-30c lowers plasma lipids without causing steatosis. The studies herein suggest that miR-30c targets both apoBlipoprotein production and lipid synthesis; they work together as anti-hyperlipidemic and atheroprotective. Elucidation of improved binding to MTP mRNA and another lipid metabolism pathway targeted by miR-30c may help develop new therapeutic options. Development of a treatment modality using miR-30c may be beneficial in lowering plasma lipids.
Citation
Soh, J. (2012). MicroRNA-30c Reduces Hyperlipidemia and Atherosclerosis by Decreasing Lipid Synthesis and Lipoprotein Secretion. [Doctoral dissertation, SUNY Downstate Health Sciences University]. SUNY Open Access Repository. https://soar.suny.edu/handle/20.500.12648/16091
DOI
Description
Doctoral Dissertation